Enguehard-Gueiffier Cécile, Hübner Harald, El Hakmaoui Ahmed, Allouchi Hassan, Gmeiner Peter, Argiolas Antonio, Melis Maria Rosaria, Gueiffier Alain
Laboratoire de Chimie Thérapeutique, Faculté de Pharmacie, 31 avenue Monge, F-37200 Tours, France.
J Med Chem. 2006 Jun 29;49(13):3938-47. doi: 10.1021/jm060166w.
A series of novel 2-[(4-phenylpiperazin-1-yl)methyl]imidazoazines and aza-analogues were prepared and screened at selected dopamine, serotonin, and adrenergic receptor subtypes. 2-Substituted imidazopyridines and pyridazines presented high affinities and selectivities for D4 dopamine receptors. Whereas functional experiments indicated neutral antagonists or weak partial agonist effects for most of the target compounds, the 2-methoxyphenyl substituted 2-piperazinylmethylimidazopyridine 3c (PIP3EA) displayed substantial agonist efficacy in mitogenesis experiments and GTPgammaS binding tests, resulting in EC50 values of 3.0 (46%) and 4.5 nM (57%), respectively. Our D4 agonist 3c induced penile erection in vivo when administered to rats. This effect was inhibited by L-745,870 a D4 selective antagonist, confirming the mechanistic pathway.
合成了一系列新型的2-[(4-苯基哌嗪-1-基)甲基]咪唑嗪及其氮杂类似物,并在选定的多巴胺、5-羟色胺和肾上腺素能受体亚型上进行了筛选。2-取代的咪唑并吡啶和哒嗪对D4多巴胺受体具有高亲和力和选择性。虽然功能实验表明大多数目标化合物为中性拮抗剂或弱部分激动剂作用,但2-甲氧基苯基取代的2-哌嗪基甲基咪唑并吡啶3c(PIP3EA)在有丝分裂实验和GTPγS结合试验中表现出显著的激动剂效力,其EC50值分别为3.0(46%)和4.5 nM(57%)。我们的D4激动剂3c给大鼠给药时可在体内诱导阴茎勃起。D4选择性拮抗剂L-745,870可抑制此效应,从而证实了其作用机制途径。